Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.44 |
| 52-week change 3 | 38.15% |
| S&P500 52-week change 3 | -7.17% |
| 52-week high 3 | 324.75 |
| 52-week low 3 | 225.28 |
| 50-day moving average 3 | 304.62 |
| 200-day moving average 3 | 288.24 |
Share statistics
| Avg vol (3-month) 3 | 1.49M |
| Avg vol (10-day) 3 | 1.63M |
| Shares outstanding 5 | 256.69M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 256.05M |
| % held by insiders 1 | 0.19% |
| % held by institutions 1 | 96.78% |
| Shares short (29 Dec 2022) 4 | 2.5M |
| Short ratio (29 Dec 2022) 4 | 1.67 |
| Short % of float (29 Dec 2022) 4 | 0.98% |
| Short % of shares outstanding (29 Dec 2022) 4 | 0.97% |
| Shares short (prior month 29 Nov 2022) 4 | 2.81M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 23 Aug 2000 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 37.62% |
| Operating margin (ttm) | 36.89% |
Management effectiveness
| Return on assets (ttm) | 13.68% |
| Return on equity (ttm) | 29.02% |
Income statement
| Revenue (ttm) | 8.7B |
| Revenue per share (ttm) | 34.05 |
| Quarterly revenue growth (yoy) | 17.70% |
| Gross profit (ttm) | 3.62B |
| EBITDA | 3.35B |
| Net income avi to common (ttm) | 3.27B |
| Diluted EPS (ttm) | 12.73 |
| Quarterly earnings growth (yoy) | 9.20% |
Balance sheet
| Total cash (mrq) | 9.77B |
| Total cash per share (mrq) | 38.06 |
| Total debt (mrq) | 824.6M |
| Total debt/equity (mrq) | 6.33 |
| Current ratio (mrq) | 4.70 |
| Book value per share (mrq) | 50.77 |
Cash flow statement
| Operating cash flow (ttm) | 4.05B |
| Levered free cash flow (ttm) | 2.47B |
© 2023 Yahoo. All rights reserved.
